SPOTLIGHT – October, 2018
Supporting health system transformation through an interprofessional education experience focused on population health

Kari F. Brisolara, Sonia Gasparini, Alison H. Davis, Shane Sanne, Sandra Carlin Andrieu, Jerald James, Donald E. Mercante, Raquel Baroni De Carvalho & Tina Patel Gunaldo

The purpose of this study according to Dr. Kari Brisolara, of the LSUHSC School of Public Health, was to determine the impact of an interprofessional education (IPE) experience on first year students across all schools of a health sciences center on the topic of pediatric immunizations. The research team conducted a pre-/post-test at Louisiana State University Health Sciences Center-New Orleans with 731 first year students from 25 academic programs encompassing all six schools (Allied Health, Dentistry, Graduate Studies, Medicine, Nursing and Public Health). In the four questions related to the Interprofessional Education Collaborative (IPEC) sub-competencies and the three questions related to professional role regarding immunizations, there was a statistically significant difference in the pre-/post-test survey results (< 0.0001). Student learning related to the collaboration needed to make a larger impact on patient outcomes was demonstrated through assessment of an open-ended question. IPE experiences can improve first-year students’ perceptions of IPEC sub-competencies regarding the importance of population health and teamwork. By utilizing a population health focus with IPE activities, novice learners are equipped to learn and apply collaborative practice skills along with recognizing the importance of promoting overall health and well-being instead of just health care.

READ MORE


A Partnership in Health-Related Social Media for Young Breast Cancer Survivors

Donna L. Williams, DrPH, Timiya S. Nolan, PhD, Yu-wen Chiu, DrPH, MPH, Laura Ricks, MPH, Silvia Gisiger Camata,MPH, Barbara Craft, MD, Karen Meneses, PhD

In the United States, about 11% (26,393) of those diagnosed with breast cancer in 2016 will be young or less than 45 years old. Young breast cancer survivors, compared to older cancer survivors, are a disparate group that experience higher incidence of advanced disease, greater mortality, and poorer quality of life, and are often faced with difficulty locating support that meets the unique needs of young women. The Gulf States Young Breast Cancer Survivor Network, composed of three sister networks, formed a partnership aimed at harnessing the power of social media to reach and impact the lives of young women with breast cancer. The collaborative partnership framework and the power of synergy are shown in merging two existing programs and incorporating a third new program.

READ MORE


A Platform for Monitoring Fiscal Health and Sustainability of the Public Health System

According to a new study titled, “The Public Health Uniform National Data System (PHUND$): A Platform for Monitoring Fiscal Health and Sustainability of the Public Health System,” published in the Journal of Public Health Management and Practice on August 13, 2018, it states, “Leaders of government agencies are responsible for stewardship over taxpayer investments. Stewardship […]

READ MORE  


Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination ~ Andrew G. Chapple and Peter F. Thall

A Bayesian design is presented that does precision dose finding based on time to toxicity in a phase I clinical trial with two or more patient subgroups. The design, called Sub-TITE, makes sequentially adaptive subgroup-specific decisions while possibly combining subgroups that have similar estimated dose-toxicity curves. Decisions are based […]

READ MORE  


Analyzing over diagnosis risk in cancer screening: A case of screening mammography for breast cancer ~ Mahboubeh Madadi, Mohammadhossein Heydari, Shengfan Zhang, Edward Pohl, Chase Rainwater & Donna L. Williams

Overdiagnosis is defined as the diagnosis of an asymptotic cancer that would not have presented clinically in a patient’s lifetime in the absence of screening. Quantifying overdiagnosis is difficult, since it is impossible to distinguish between a cancer that would cause symptoms in the patient lifetime and the ones that would not. In this study, a mathematical framework is developed to estimate the lifetime overdiagnosis and cancer mortality risks associated with cancer screening policies […]

READ MORE  

 LATEST RESEARCH NEWS – Fall 2018